Floatz logo

(+)-VINCRISTINE

Anaplastic Mixed Oligoastrocytoma

Patrick Y. Wen, MDSmall moleculePhase 2Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Anaplastic Mixed Oligoastrocytoma cohort.

Asset / SponsorPhaseRating
Irinotecan
City of Hope Medical Center
Phase 2BB
Tandutinib
National Cancer Institute (NCI)
Phase 2B
Carboplatin
National Cancer Institute (NCI)
Phase 2B
Zactima
National Cancer Institute (NCI)
Phase 2B
Talampanel
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2CCC

Same molecule, other indications

(+)-VINCRISTINE is also rated in:

anaplastic large cell lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →